生物活性 | |||
---|---|---|---|
描述 | AKI603, an Aurora kinase A (AurA) inhibitor with an IC50 of 12.3 nM, is designed to counteract resistance from the BCR-ABL-T315I mutation. It demonstrates potent anti-proliferative effects in leukemic cells[1][2]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.44mL 0.49mL 0.24mL |
12.21mL 2.44mL 1.22mL |
24.42mL 4.88mL 2.44mL |
参考文献 |
---|